Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
暂无分享,去创建一个
S. Sivapalaratnam | K. Pasi | D. Hart | P. Maccallum | S. Platton | L. Bowles | Laura Green | Kurtis Lee | Nada Yartey | Minal Dave | Vickie MacDonald
[1] Toshiaki Iba,et al. The unique characteristics of COVID-19 coagulopathy , 2020, Critical Care.
[2] D. Roccatello,et al. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients , 2020, Internal and Emergency Medicine.
[3] Mickaël Ohana,et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.
[4] M. Ramakers,et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients , 2020, Journal of Thrombosis and Haemostasis.
[5] D. Gommers,et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.
[6] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[7] B. Cantinieaux,et al. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding‐related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre‐operative screening , 2016, European journal of haematology.
[8] M. Laffan,et al. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis , 2013, International journal of laboratory hematology.
[9] M. Makris,et al. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal , 2011, International journal of laboratory hematology.
[10] T. Ortel,et al. Update of the guidelines for lupus anticoagulant detection , 2009, Journal of thrombosis and haemostasis : JTH.
[11] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[12] D. W. Jones,et al. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII , 2000, British journal of haematology.
[13] S. Kitchen,et al. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. , 1998, Clinical and laboratory haematology.